Origins of replication are activated throughout the S phase of the cell cycle such that some origins fire early and others fire late to ensure that each chromosome is completely replicated in a timely fashion. However, in response to DNA damage or replication fork stalling, eukaryotic cells block activation of unfired origins. Human cells derived from patients with ataxia telangiectasia are deficient in this process due to the lack of a functional ataxia telangiectasia mutated (ATM) kinase and elicit radioresistant DNA synthesis 1-3 after c-irradiation 2 . This effect is conserved in budding yeast, as yeast cells lacking the related kinase Mec1 (ATM and Rad3-related (ATR in humans)) also fail to inhibit DNA synthesis in the presence of DNA damage 4 . This intra-S-phase checkpoint actively regulates DNA synthesis by inhibiting the firing of late replicating origins, and this inhibition requires both Mec1 and the downstream checkpoint kinase Rad53 (Chk2 in humans) 5,6 . However, the Rad53 substrate(s) whose phosphorylation is required to mediate this function has remained unknown. Here we show that the replication initiation protein Sld3 is phosphorylated by Rad53, and that this phosphorylation, along with phosphorylation of the Cdc7 kinase regulatory subunit Dbf4, blocks late origin firing in Saccharomyces cerevisiae. Upon exposure to DNAdamaging agents, cells expressing non-phosphorylatable alleles of SLD3 and DBF4 (SLD3-m25 and dbf4-m25, respectively) proceed through the S phase faster than wild-type cells by inappropriately firing late origins of replication. SLD3-m25 dbf4-m25 cells grow poorly in the presence of the replication inhibitor hydroxyurea and accumulate multiple Rad52 foci. Moreover, SLD3-m25 dbf4-m25 cells are delayed in recovering from transient blocks to replication and subsequently arrest at the DNA damage checkpoint. These data indicate that the intra-S-phase checkpoint functions to block late origin firing in adverse conditions to prevent genomic instability and maximize cell survival.
Origins of replication are activated throughout the S phase of the cell cycle such that some origins fire early and others fire late to ensure that each chromosome is completely replicated in a timely fashion. However, in response to DNA damage or replication fork stalling, eukaryotic cells block activation of unfired origins. Human cells derived from patients with ataxia telangiectasia are deficient in this process due to the lack of a functional ataxia telangiectasia mutated (ATM) kinase and elicit radioresistant DNA synthesis 1-3 after c-irradiation 2 . This effect is conserved in budding yeast, as yeast cells lacking the related kinase Mec1 (ATM and Rad3-related (ATR in humans)) also fail to inhibit DNA synthesis in the presence of DNA damage 4 . This intra-S-phase checkpoint actively regulates DNA synthesis by inhibiting the firing of late replicating origins, and this inhibition requires both Mec1 and the downstream checkpoint kinase Rad53 (Chk2 in humans) 5, 6 . However, the Rad53 substrate(s) whose phosphorylation is required to mediate this function has remained unknown. Here we show that the replication initiation protein Sld3 is phosphorylated by Rad53, and that this phosphorylation, along with phosphorylation of the Cdc7 kinase regulatory subunit Dbf4, blocks late origin firing in Saccharomyces cerevisiae. Upon exposure to DNAdamaging agents, cells expressing non-phosphorylatable alleles of SLD3 and DBF4 (SLD3-m25 and dbf4-m25, respectively) proceed through the S phase faster than wild-type cells by inappropriately firing late origins of replication. SLD3-m25 dbf4-m25 cells grow poorly in the presence of the replication inhibitor hydroxyurea and accumulate multiple Rad52 foci. Moreover, SLD3-m25 dbf4-m25 cells are delayed in recovering from transient blocks to replication and subsequently arrest at the DNA damage checkpoint. These data indicate that the intra-S-phase checkpoint functions to block late origin firing in adverse conditions to prevent genomic instability and maximize cell survival.
In a whole-genome screen for proteins whose electrophoretic mobility was altered by DNA damage (L.G.D.E. and D.P.T., unpublished results), we found that Sld3, an essential protein required for the initiation of DNA replication in budding yeast 7 , becomes substantially modified in response to checkpoint activation. Sld3 was hyperphosphorylated in cells treated with genotoxic drugs, but not in cells arrested at the spindle checkpoint with nocodazole ( Fig. 1a, b ). The Sld3 damage-induced phosphorylation depends on Mec1 and Rad53 and is compromised in mutants with reduced Rad53 activation ( Fig.  1c ). DNA-damage-induced Sld3 phosphorylation is not cell-cycle regulated, as cells blocked in G1 or mitosis and subsequently treated with 4-nitroquinoline 1-oxide (4NQO) or zeocin contained phosphorylated Sld3 (Fig. 1d ).
Origin firing requires both the phosphorylation of Sld3 by the Sphase cyclin-dependent kinase (CDK) 8, 9 and the activity of the Dbf4dependent kinase (DDK) 10, 11 . The S-phase CDK phosphorylation of Sld3 allows binding to Dpb11 and promotes origin firing 8, 9 . In vitro binding assays using recombinant full-length Sld3 and immobilized Dpb11 revealed that S-phase CDK phosphorylation of Sld3 is required to bind Dpb11, as previously seen 8, 9 . However, subsequent Rad53 phosphorylation of S-phase-CDK-phosphorylated Sld3 eliminated binding to Dpb11 (Fig. 1e ). This indicates that Sld3 is a Rad53 substrate and suggests that, by antagonizing Sld3 binding to Dpb11, Rad53 can inhibit late origin firing.
To address this hypothesis directly, we constructed an unphosphorylatable SLD3 allele. Using mass spectrometry, 28 phosphorylation sites were identified ( Supplementary Table 1a ). Twenty-five potential phosphorylation sites were mutated to generate the SLD3-m25 allele. When SLD3-m25 was introduced into cells, damage-induced Sld3 phosphorylation was not detected ( Fig. 2a and Supplementary Fig. 2 ). (ultraviolet mimetic; 2 mg ml 21 ), or nocodazole (10 mg ml 21 ) for 90 min. b, Phosphatase assays of Sld3-3Flag and Dbf4-TAP (tandem affinity purification) purified from MMS-treated cells. c, Immunoblot of checkpoint deletion mutants expressing Sld3-9Myc (w303). Samples were taken from cells arrested in G1 with a-factor and released in the presence or absence of MMS for 180 min. d, Immunoblot of cells expressing Sld3-9Myc (w303) arrested in G1 with a-factor or metaphase with nocodazole for 120 min and then treated with either 4NQO or zeocin, as in a, for 60 min. Asterisk denotes a background band. e, In vitro binding assay. Recombinant Sld3-3Flag mock phosphorylated (2), Clb5-TAP CDK phosphorylated or Clb5-TAP CDK phosphorylated followed by Rad53 phosphorylation. Ten per cent of the untreated Sld3-3Flag is shown as input. Immobilized Dpb11-TAP was used to pull down the differentially phosphorylated Sld3 species.
In vitro kinase assays revealed that activated Rad53, but not a catalytic mutant (Rad53(K227A)), phosphorylated Sld3 strongly, but phosphorylated the Sld3-m25 mutant less efficiently ( Fig. 2b ). Additional mass spectrometry analysis of Sld3 phosphorylated in vitro by Rad53 identified nine phosphorylation sites, five of which were mutated in the SLD3-m25 allele ( Supplementary Table 1a ). Intra-S-phase checkpoint-defective mutants, such as rad53D, fail to prevent late origin firing in the presence of DNA damage and consequently proceed through the S phase faster than wild-type cells 5, 6 . Cells expressing SLD3-m25 in the presence of methyl methanesulphonate (MMS) proceeded through the S phase faster than wild-type cells ( Fig.  2c, d ), although they progressed slower than rad53D cells. Like Sld3, Dbf4 functions to promote firing of all origins of replication and is phosphorylated in response to checkpoint activation in a Rad53dependent manner 12, 13 (Figs 1b and 2a ). Dbf4 is a periodically expressed activator of the Cdc7 kinase, which is known to phosphorylate the replication helicases (MCMs) [14] [15] [16] [17] . We reasoned that Dbf4 may also be inhibited by Rad53 to block late origin firing. Using a similar mass-spectrometry approach, six phosphorylation sites were identified on Dbf4 ( Supplementary Table 1b ). The six phosphorylation sites were mutated to generate the dbf4-m6 allele; however, the Dbf4 damage-induced phosphorylation shift was intact when dbf4-m6 cells were treated with MMS (data not shown). Previous studies have shown that a Dbf4 mutant lacking the non-essential amino terminus (1-109) is not phosphorylated in damage-treated cells 18 . For this reason, we mutated all serine and threonine residues in this non-essential domain of Dbf4 (except those matching the CDK consensus sequence), in addition to the six sites identified by mass spectrometry, to generate the dbf4-m25 allele. Damage-induced Dbf4-m25 phosphorylation was reduced, but not eliminated ( Fig. 2a ), indicating that not all damageinduced phosphorylation sites were identified or that Dbf4 is also phosphorylated by another damage-responsive kinase(s).
Cells expressing SLD3-m25, dbf4-m25 or both mutant alleles were viable and had no growth defects at any temperature tested ( Supplementary Figs 3 and 4a ). Cells expressing dbf4-m25 alone seem to be intra-S-phase checkpoint competent ( Fig. 2c, d ). However, cells expressing SLD3-m25 and dbf4-m25 progressed faster through the S phase in the presence of MMS than cells expressing either allele alone ( Fig. 2c, d and Supplementary Fig. 5 ), suggesting that Sld3 and Dbf4 are both important for the block to late origin firing. The finding that SLD3-m25 dbf4-m25 cells progressed through the S phase slower than rad53D cells can best be explained by the fact that Dbf4-m25 is still partially phosphorylated in vivo ( Fig. 2a ). Damage-induced Rad53 phosphorylation and Sml1 degradation 19 are intact in SLD3-m25 dbf4-m25 cells ( Fig. 2a ), indicating that these mutations do not compromise checkpoint activation.
To determine unambiguously whether the fast S phase observed in SLD3-m25 dbf4-m25 cells, in the presence of MMS, is due to the inappropriate firing of late origins of replication, firing was directly analysed by two-dimensional gel electrophoresis 20 . In hydroxyureatreated cells, early origins ARS305 and ARS607 fired efficiently and with normal kinetics in SLD3-m25, dbf4-m25 and SLD3-m25 dbf4-m25 mutants compared to wild-type cells ( Fig. 3a and Supplementary Fig.  6b ). This finding is consistent with early origins being refractory to intra-S-phase checkpoint regulation 5, 6 . We next looked at several late origins: ARS501, ARS609, ARS1007 and ARS1212 ( Fig. 3a , Supplementary Fig. 6c and data not shown). In hydroxyurea-treated cells, late origin firing was not detected in wild-type cells, but was evident in rad53D cells. Inappropriate late origin firing was also observed in SLD3-m25, dbf4-m25 and most strongly in the SLD3-m25 dbf4-m25 double mutant. In these mutant cells, late origins fired after early origins, confirming the finding that the temporal regulation of origin firing is not subject to intra-S-phase checkpoint regulation ( Supplementary Fig. 6b, c) . These results suggest that the fast S phase observed in SLD3-m25 dbf4-m25 cells is due to the inappropriate firing of late replicating origins.
If Rad53-mediated phosphorylation of Sld3 slows the S phase by blocking late origin firing, then constitutive Rad53 phosphorylation of 
Figure 2 | SLD3-m25 and dbf4-m25 cells are intra-S-phase checkpoint defective. a, Immunoblots from asynchronous cells grown in the presence or absence of 0.05% MMS for 90 min (w303). rad53(K227A) is a hypomorphic allele that is checkpoint-defective, but able to perform the essential function rescued by Sml1 deletion. b, Immunoblots of an in vitro kinase assay on recombinant full-length Sld3 or Sld3-m25 substrates treated with yeast Clb5-TAP CDK, recombinant Rad53 or Rad53(K227A). c, Flow cytometry of wildtype, SLD3-m25, dbf4-m25, SLD3-m25 dbf4-m25, or rad53D cells synchronized in G1 with a-factor and released into 0.033% MMS at 30 uC. d, The 60 and 90 min profiles from c, displayed together.
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Sld3 would constitutively slow the S phase, even in the absence of DNA-damaging agents. To test this prediction, we created a phospho-mimetic allele, where 21 residues targeted by Rad53 were mutated to aspartic acids to mimic constitutive Sld3 phosphorylation (sld3-m21D). Cells expressing the sld3-m21D allele revealed a slow S phase in the absence or presence of DNA-damaging agents ( Fig. 3b and Supplementary Fig. 7a ). The slow S phase is not a result of checkpoint activation, as sld3-m21D cells do not elicit Rad53 phosphorylation in the absence of damage ( Supplementary Fig. 7b ). In addition, sld3-m21D cells grow with wild-type rates, are not hydroxyurea sensitive, and fire early origins of replication with efficiencies that are indistinguishable from those observed in wild-type cells ( Fig. 3c and Supplementary Fig. 7c ). This suggests that Sld3 phosphorylation is sufficient to inhibit origin firing, although effects on other aspects of replication may also have a contribution ( Supplementary Fig. 1 ). An Sld3-Dpb11 fusion has previously been shown to bypass the requirement for S-phase CDK activity for origin firing 9 . If Rad53 phosphorylation of Sld3 functions solely to inhibit an Sld3-Dpb11 interaction, then cells expressing an Sld3-Dpb11 fusion should be intra-S-phase checkpoint defective, akin to the SLD3-m25 allele. However, cells expressing the Sld3-Dpb11 fusion were neither intra-S-phase checkpoint defective ( Supplementary Fig. 8 ) nor sensitive to growth on DNA-damaging agents (data not shown). This suggests that, although Rad53 inhibits the Sld3-Dpb11 interaction, this inhibition is not sufficient to block late origin firing.
To test if growth of SLD3-m25 dbf4-m25 cells is impaired by DNAdamaging agents, cells were spotted on hydroxyurea and MMS plates and sensitivity was compared to wild-type and rad53D cells. SLD3-m25 dbf4-m25 cells are mildly sensitive to the replication inhibitor hydroxyurea in a dosage-dependent manner ( Fig. 3c and Supplementary Fig. 4b ), but were not sensitive to MMS (data not shown). Notably, mec1-100 cells, which are defective in the block to late origin firing, are also mildly hydroxyurea sensitive, but not MMS sensitive 21, 22 . It is possible that SLD3-m25 dbf4-m25 cells are sensitive to hydroxyurea simply because these mutant alleles are hypomorphic. Two results indicated that this was not the case. First, the checkpointdefective rad53-R70,R605A allele is epistatic to SLD3-m25 dbf4-m25: SLD3-m25 dbf4-m25 rad53-R70,R605A cells were not more hydroxyurea sensitive than rad53-R70,R605A cells ( Supplementary Fig. 9a,  b) . Second, SLD3-m25 is dominant to wild type for hydroxyurea sensitivity. In hydroxyurea-sensitivity experiments using heterozygous diploid cells (Fig. 3e ), homozygous SLD3/SLD3 dbf4-m25/dbf4-m25 diploid cells are resistant to hydroxyurea. In contrast, heterozygous SLD3/SLD3-m25 dbf4-m25/dbf4-m25 diploid cells are mildly hydroxyurea sensitive, similarly to homozygous SLD3-m25/SLD3-m25 dbf4-m25/dbf4-m25 diploid cells (Fig. 3e ). SLD3-m25 is similarly dominant for its checkpoint phenotype. These results strongly suggest that the hydroxyurea sensitivity seen in the SLD3-m25 dbf4-m25 double mutant is not due to insufficient Sld3 activity in the SLD3-m25 allele, but instead is due to it being refractory to Rad53 inhibition.
Previous studies have shown that wild-type cells can efficiently recover from hydroxyurea arrest, whereas rad53D cells cannot 23, 24 . We asked if SLD3-m25 dbf4-m25 cells could recover from transient blocks to DNA replication. Wild-type, SLD3-m25 and dbf4-m25 single mutant cells recovered from hydroxyurea arrest and divided, entering the next cell cycle by 120 min (Fig. 4a) . However, only a fraction of SLD3-m25 dbf4-m25 cells appeared to recover from hydroxyurea arrest by 120 min; the majority remained arrested in mitosis, 
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Release into 0.033% MMS Asynch. Wild-type, SLD3-m25, dbf4-m25, SLD3-m25 dbf4-m25 or rad53D cells were synchronized with a-factor and released into 200 mM hydroxyurea. Cells were collected at 30, 40, 50, 60 and 70 min into the hydroxyurea release and pooled. Twenty microgram aliquots of DNA were analysed by two-dimensional electrophoresis as previously described 20 . Early origins, ARS305 and ARS607; late origins, ARS501 and ARS609. b, Flow cytometry of cells expressing SLD3-3Flag or a phosphorylation-mimetic allele sld3-m21D-3Flag. Cells were arrested in G1 with a-factor and released into media without a-factor at 30 uC. c, Fivefold serial dilutions of wild-type or mutant strains grown on 0 mM, 50 mM, 100 mM, or 200 mM hydroxyurea. d, Flow cytometry of diploid MAT a/a cells treated as in Fig. 2c , from SLD3/SLD3 dbf4-m25/dbf4-m25, SLD3/ SLD3-m25 dbf4-m25/dbf4-m25 and SLD3-m25/SLD3-m25 dbf4-m25/dbf4-m25 cells. e, Fivefold serial dilutions, as in c, of diploid strains to assess dominance. S, wild-type SLD3; D, wild type DBF4; s, SLD3-m25; d, dbf4-m25.
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indicating that these cells harboured DNA damage (Fig. 4a ). We then examined Rad53 de-phosphorylation kinetics. In wild-type, SLD3-m25 and dbf4-m25 cells, Rad53 became phosphorylated during the hydroxyurea arrest and was de-phosphorylated after the hydroxyurea release. In contrast, SLD3-m25 dbf4-m25 cells retained Rad53 phosphorylation for 120 min after hydroxyurea release (Fig. 4b) .
Although it is likely that inappropriate firing of late origins leads to a proportional increase in fork collapse, Sld3 phosphorylation probably provides additional hydroxyurea resistance through other uncharacterized means. Rad52 functions in recombinational repair and can potentially repair or restart broken or stalled replication forks. Rad52-GFP foci have been shown to form in response to replication fork collapse during the S phase in several checkpoint mutants 25, 26 . In wild-type cells, however, foci were not observed when cells are treated with either hydroxyurea or MMS 25, 27 . Consistently, we observed Rad52-GFP foci in 3% of wild-type and 53% of rad53D cells treated with hydroxyurea. Interestingly, 32% of SLD3-m25 dbf4-m25 cells treated with hydroxyurea formed Rad52-GFP foci (Fig. 4c) , with some cells containing multiple foci ( Supplementary Figs 10-12 ). We also observed that SLD3-m25 dbf4-m25 double mutant cells exhibited a 50% viability loss after a 4-h hydroxyurea treatment (Fig. 4d) . Consistent with the observed increase in Rad52 foci, the mild viability loss seen in SLD3-m25 dbf4-m25 cells after transient hydroxyurea treatment is exacerbated when RAD52 is also deleted. This indicates that in hydroxyurea, SLD3-m25 dbf4-m25 cells repair DNA damage by homologous recombination to survive. As expected, rad53D cells show a severe viability loss after hydroxyurea treatment due the additional roles of Rad53 in fork stabilization 23, 24 . Taken together, these data indicate that failure to block late origins in the presence of replication inhibitors results in an increased number of stalled replication forks, and perhaps increases the propensity of replication fork collapse. Rad52-dependent pathways may function to resolve or restart these stalled forks and its loss probably generates problems at the fork that ultimately contribute to cell lethality.
DNA replication and the intra-S-phase checkpoint machinery are conserved in organisms ranging from yeast to human. Recently several vertebrate candidate Sld3 orthologues have been identified, including Treslin (also called ticrr), GEMC1 and DUE-B 28 . Of these candidates, Treslin shares significant domain conservation with Sld3 (ref. 29) . It remains to be seen if ATM/ATR or Chk2 also inhibit any of these new DNA replication factors upon DNA damage.
METHODS SUMMARY
Western blotting. An equivalent of six optical density at 600 nm (OD 600 ) cells were pelleted, washed with cold water, and re-suspended in pre-heated SDS sample buffer (50 mM Tris pH 7.5, 5 mM EDTA, 5% SDS, 10% glycerol, 0.5% bmercaptoethanol, 0.05% bromophenol blue, 1 mg ml 21 leupeptin, 1 mg ml 21 pepstatin A, 1 mM benzamidine, 17 mg ml 21 PMSF, 5 mM sodium fluoride, 80 mM bglycerophosphate and 1 mM sodium orthovanadate). Cells were lysed by bead beating for 3 min in a Mini BeadBeater (Biospec) using 100 ml glass beads. Samples were then centrifuged at 15,000 r.p.m. and heated to 95 uC for 5 min and clarified by centrifugation. Extracts were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and probed with antibodies against Flag (Clone M2, Sigma), Rad53 (rabbit anti-Rad53 provided by D. Durocher), Myc (9E10) and the TAP tag (rabbit anti-CBP, provided by J. Weissman). Two-dimensional gel electrophoresis. Asynchronous cultures were harvested at OD 600 of ,1. Synchronized cultures were held in G1 with a-factor until 90% of cells were unbudded. a-factor was washed out and cells were re-suspended in media pre-warmed to 30 uC containing 200 mM hydroxyurea. At the indicated time points, aliquots were collected and all samples were processed as previously described 20 . DNA was digested with Pst1 for ARS607, Xba1 for ARS501, and EcoR1 for ARS305 and ARS609. DNA probes were labelled using the Prime-it II kit (Stratagene).
A full description of methods is provided in the Methods. Strains and plasmids are listed in Supplementary Tables 2 and 3 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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METHODS
All yeast strains used in this study are of the s288c strain background unless otherwise noted and were created using standard yeast techniques. All constructs were sequence verified.
Epitope tagging of Sld3 at the endogenous locus was done by integration as follows: the 3Flag::HygroR cassette 30 was targeted to the SLD3 ORF to yield SLD3-3Flag::HygMx (yJLO18). SLD3-3Flag::HygMx was PCR amplified from yJLO18 and cloned into pGEM-T-easy (Promega) to generate pJLO2. Mutagenesis of Sld3 at the endogenous locus was done by integration as follows: pJLO2 was mutated using QuikChange site-directed mutagenesis (Stratagene) following the manufacturer's instructions. Resultant plasmids were then digested to release constructs used to transform diploid strains (for example, (yNLM133) SLD3-m25-3Flag::HygMx; pNM23 was digested to release a StuI/BstZ17I fragment used to target SLD3). T607A, T609A, T631A and T638A were not identified by mass spectrometry but were mutated because these sites are present in a peptide shown to bind Dpb11 in vitro 8, 9 . To create sld3-m21D-3Flag, a DNA fragment including amino acids corresponding to the last 21 mutations in the SLD3-m25-3Flag allele was synthesized, such that each of these 21 phosphorylation sites were now mutated to aspartic acids, and cloned into pJ201 (DNA 2.0). An EcoN1/BamH1 fragment (857 bp) was subcloned into pNM14 digested with EcoN1/BamH1. The resulting plasmid, pJLO18, was then digested with EcoN1 and Bstz17I to integrate it at the endogenous SLD3 locus in diploid cells. Diploids were subsequently sporulated to obtain haploid cells.
Dbf4 was cloned into pGEM-T-easy to generate pJLO12. Mutations identified by mass spectrometry were mutated using QuikChange mutagenesis as described above to generate pJLO15. Mutations in the Dbf4 N-terminal domain were synthesized and cloned into pUC57 (Bio-Basic). A SacII/BsaBI fragment from pUC57 was subcloned into pJLO15 to generate pJLO16. pJLO16 was modified by QuikChange mutagenesis to revert mutations (A3S A11S) to generate pJLO17. pJLO17 was digested with SacII to integrate into yJLO110 at the dbf4D::KanMx locus. Rad53-R70A,R605A (FHA1 FHA2 mutants). A heterozygous diploid SLD3/ SLD3-m25 RAD53/rad53D DBF4/dbf4-m25 SML1/sml1-1 was transformed with a CEN plasmid harbouring rad53-R70A,R605A::URA3. Resultant transformants were sporulated and dissected. Previous work has shown that Rad53 has an additional direct role in DNA replication leading to synthetic lethal interactions with cdc7 or dbf4 alleles 31 . This interaction is checkpoint-independent, as RAD53 alleles with mutations in both FHA domains, which lack all checkpoint functions 32, 33 , are fully competent for this checkpoint-independent function. To avoid complications arising from this, we have used this rad53 allele.
MAT a/a diploids were created by transforming a/a diploid cells with a CEN plasmid containing pGal-HO::URA3. Mating-type switching was induced with 2% galactose for 30 min. Diploids were then plated on 5-FOA to lose the plasmid. Resulting diploids were then tested for the ability to arrest in G1 with a-factor. Phosphatase assay. Sld3-3Flag or Dbf4-TAP was overexpressed and immunoprecipitated using anti-M2 Flag sepharose (Sigma) or IgG sepharose (GE Healthcare) from cells treated with 0.05% MMS or 2 mg ml 21 4NQO. Immunoprecipitates were washed twice in l-phosphatase buffer and treated with 100 units of l-phosphatase (NEB) for 30 min at 30 uC in the presence or absence of phosphatase inhibitors (ZnCl 2 , 1 mM NaF, 1 mM Na-orthovanadate). Flow cytometry. Yeast cells were fixed with 70% ethanol and stored at 4 uC. Cells were then sonicated, treated with 0.25 mg ml 21 RNase A for 1 h at 50 uC, followed by digestion with 0.125 mg ml 21 proteinase K for 1 h at 50 uC and labelling with 1 mM Sytox Green (Invitrogen). Data were collected using a FACSCalibur (Becton Dickinson) and analysed with FlowJo software (Tree Star, Inc.). Two-dimensional gel electrophoresis. Asynchronous cultures were harvested at an optical density at 600 nm (OD 600 ) of ,1. Synchronized cultures were held in G1 with a-factor until 90% of cells were unbudded. a-Factor was washed out and cells were re-suspended in media pre-warmed to 30 uC containing 200 mM hydroxyurea. At the indicated time points, aliquots were collected and all samples were processed as previously described 20 . DNA was digested with Pst1 for ARS607, Xba1 for ARS501, and EcoR1 for ARS305 and ARS609. DNA probes were labelled using the Prime-it II kit (Stratagene). Spot assays. Mid-log cultures were diluted to OD 600 5 0.5. Cultures were subjected to fivefold serial dilution and 5 ml were spotted on plates containing various hydroxyurea concentrations. Plates were subsequently incubated at 30 uC for 18-36 h. Hydroxyurea survival assay. Overnight cultures were diluted to OD 600 5 0.3 and incubated at 30 uC for 2 h before synchronizing in G1 with a-factor for an additional 2 h. a-Factor was washed out and cells were re-suspended in pre-warmed media containing 200 mM hydroxyurea. At the indicated time points, 200 ml of each culture was diluted 5,000-fold in media and 200 ml of cells were plated and subsequently grown at 30 uC for 36 h. For asynchronous cultures, cells were diluted back to OD 600 5 0.3 for 2 h before treating with 0 mM, 12.5 mM, 25 mM, or 50 mM
